platycodin d has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, MH; Li, W; Qi, SM; Shen, Q; Wang, YP; Wang, Z; Zhang, JT | 1 |
| Chen, T; Chen, Y; Gao, J; Ji, H; Ji, J; Lan, L; Wang, S; Wei, Y; Wu, H; Xiang, P; Xiao, W; Xie, P; Yan, T | 1 |
2 other study(ies) available for platycodin d and Alloxan Diabetes
| Article | Year |
|---|---|
Platycodin D inhibits HFD/STZ-induced diabetic nephropathy via inflammatory and apoptotic signaling pathways in C57BL/6 mice.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Glucose; Lipids; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; NF-kappa B; Signal Transduction; Streptozocin | 2023 |
Protective effect of platycodin D on liver injury in alloxan-induced diabetic mice via regulation of Treg/Th17 balance.
Topics: Alanine Transaminase; Alloxan; Animals; Aspartate Aminotransferases; Blood Glucose; Chemical and Drug Induced Liver Injury; Cholesterol; Codonopsis; Cytokines; Diabetes Mellitus, Experimental; Forkhead Transcription Factors; Inflammation Mediators; Insulin; Liver; Mice; Mice, Inbred Strains; Saponins; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Th17 Cells; Triterpenes | 2015 |